P

Inventor

OLSEN OLE

US52 patents
⚠️ This page may combine multiple inventors who share the name “OLSEN OLE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THERACLONE SCIENCES INC

13 patents
US10087239B2Oct 2, 2018

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

THERACLONE SCIENCES INC14 citations91
US9464131B2Oct 11, 2016

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

THERACLONE SCIENCES INC18 citations91
US11319362B2May 3, 2022

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

THERACLONE SCIENCES INC3 citations83
US10865234B2Dec 15, 2020

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

THERACLONE SCIENCES INC1 citations72
US10836811B2Nov 17, 2020

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

THERACLONE SCIENCES INC1 citations72
US10407493B2Sep 10, 2019

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

THERACLONE SCIENCES INC1 citations72
US12312396B2May 27, 2025

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

THERACLONE SCIENCES INC0 citations62
US12018067B2Jun 25, 2024

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

THERACLONE SCIENCES INC0 citations62
US11584789B2Feb 21, 2023

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

THERACLONE SCIENCES INC0 citations62
US7982012B2Jul 19, 2011

Compositions and methods for the therapy and diagnosis of cytomegalovirus

THERACLONE SCIENCES INC1 citations62
US11845789B2Dec 19, 2023

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

THERACLONE SCIENCES INC0 citations61
US10239934B2Mar 26, 2019

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

THERACLONE SCIENCES INC0 citations51
US9920111B2Mar 20, 2018

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

THERACLONE SCIENCES INC0 citations51

CARLSBERG AS

8 patents

SYSTIMMUNE INC

7 patents

GRANDEA III ANDRES

3 patents

GRANDEA III ANDRES G

3 patents

OLSEN OLE

3 patents

(unassigned)

2 patents

CARLSBERG BREWERIES AS

2 patents

KNUDSEN SØREN

2 patents

INNOVATIVE DEV & MARKETING

1 patent

SENSYACT AB

1 patent

CHAN-HUI PO-YING

1 patent

ARCTIC MEDICAL AS

1 patent

INT AIDS VACCINE INITIATIVE INC

1 patent

NOVO NORDISK AS

1 patent

GADE MORTEN

1 patent

Showing the top 50 of 52 patents by PatentIndex Score.